Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

Autor: Nahid P; Division of Pulmonary and Critical Care Medicine, Department of Medicine at San Francisco General Hospital and Curry International Tuberculosis Center, University of California, San Francisco, CA 94110, USA. pnahid@ucsf.edu, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S
Jazyk: angličtina
Zdroj: The Journal of infectious diseases [J Infect Dis] 2012 May 15; Vol. 205 Suppl 2, pp. S159-68. Date of Electronic Publication: 2012 Apr 03.
DOI: 10.1093/infdis/jis194
Abstrakt: The development, evaluation, and implementation of new and improved diagnostics have been identified as critical needs by human immunodeficiency virus (HIV) and tuberculosis researchers and clinicians alike. These needs exist in international and domestic settings and in adult and pediatric populations. Experts in tuberculosis and HIV care, researchers, healthcare providers, public health experts, and industry representatives, as well as representatives of pertinent US federal agencies (Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, United States Agency for International Development) assembled at a workshop proposed by the Diagnostics Working Group of the Federal Tuberculosis Taskforce to review the state of tuberculosis diagnostics development in adult and pediatric populations.
Databáze: MEDLINE